OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

← British Neuroscience Association Limited

2024-09-30-accounts

Registered number: 04307833 Charity number: 1103852

BRITISH NEUROSCIENCE ASSOCIATION LIMITED (A Company Limited by Guarantee)

UNAUDITED

TRUSTEES' REPORT AND FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 SEPTEMBER 2024

BRITISH NEUROSCIENCE ASSOCIATION LIMITED

(A Company Limited by Guarantee)

CONTENTS

Page
Reference and Administrative Details of the Charity, its Trustees and Advisers 1
Trustees' Report 2 - 15
Independent Examiner's Report 16 - 17
Statement of Financial Activities 18
Balance Sheet 19 - 20
Notes to the Financial Statements 21 - 34

(A Company Limited by Guarantee)

BRITISH NEUROSCIENCE ASSOCIATION LIMITED

REFERENCE AND ADMINISTRATIVE DETAILS OF THE CHARITY, ITS TRUSTEES AND ADVISERS FOR THE YEAR ENDED 30 SEPTEMBER 2024

Trustees

Company registered number

04307833

Charity registered number

1103852

Registered office

Dorothy Hodgkin Building Whitson Street Bristol BS1 3NY

Company secretary

Dr L Ajram

Chief executive officer

Dr L Ajram

Accountants and Independent Examiner

Martin Bailey FCA Goodman Jones LLP Chartered Accountants 1st Floor Arthur Stanley House 40-50 Tottenham Street London W1T 4RN

Page 1

BRITISH NEUROSCIENCE ASSOCIATION LIMITED

(A Company Limited by Guarantee)

TRUSTEES' REPORT FOR THE YEAR ENDED 30 SEPTEMBER 2024

The Trustees present their Annual Report together with the financial statements of the Charity for the year 1 October 2023 to 30 September 2024. The Annual Report serves the purposes of both a Trustees' Report and a Directors' Report under company law. The Trustees confirm that the Annual Report and financial statements of the charitable company comply with the current statutory requirements, the requirements of the charitable company's governing document and the provisions of the Statement of Recommended Practice (SORP) applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS102) (effective 1 January 2019).

Since the Charity qualifies as small under section 382 of the Companies Act 2006, the Strategic Report required of medium and large companies under the Companies Act 2006 (Strategic Report and Directors' Report) Regulations 2013 has been omitted.

Objectives and activities

a. Our vision and purpose

The BNA is a membership organisation committed to preserve and protect health and advance public engagement in neuroscience, through supporting, promoting and representing neuroscientists and neuroscience research.

b. Our objects

The Association's objects (The Objects), as formulated in the Articles of the Association (Article 4) and in the Rules of the Association (Rule 1.3), both documents coming into force in April 2017, are:

To preserve and protect health and advance public education in neurosciences related to health and disease, in particular but not exclusively, by:

All trustees had due regard to the Charity Commission's public benefit guidance when exercising powers and duties on behalf of the charity.

Page 2

(A Company Limited by Guarantee)

BRITISH NEUROSCIENCE ASSOCIATION LIMITED

TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 30 SEPTEMBER 2024

Objectives and activities (continued)

c. Our aims

We have three interconnected aims that are central to achieving our vision and purpose, and are the means by which we deliver our objectives: these are to Inform, Connect, and Influence . The aims to Inform, Connect and Influence were arrived at through a series of strategic workshops and engagement with members, and they help the BNA Council and Committee to direct activities throughout the year.

d. Message from the Chief Executive

YE2023-24 has been a year of reshaping and strengthening the British Neuroscience Association to position us for future success. A key focus has been restructuring our Executive Team, enabling us to better execute our development plan and deliver greater value to our members and partners. We have welcomed new staff into pivotal roles, including Head of Partnerships and Development, Membership and Communities Manager, and Marketing and Communications Manager. With this new team in place, we are well-equipped to address the evolving needs of the neuroscience community and ensure meaningful support, resources, and opportunities for our members.

The year has been marked by positive progress, with membership numbers showing the largest annual increase in three years. This growth is a testament to the dedication of our team, Trustees, and most importantly, our members. As we look ahead, I am excited by the opportunities before us, and we are committed to continuing this momentum to make an even greater impact within the neuroscience sector.

In addition to our membership growth, we have been actively exploring new avenues to generate income and realise our potential to provide world-class support to our community. The development of our Training Programme, due to launch in YE2025, and the emerging Grant Partnership Programme, which has already seen success with our applications to national research grants this year, are key initiatives in this effort. These programmes will not only provide additional value to our members but also help ensure the continued sustainability and impact of the BNA.

The development plan for YE2025 is ambitious, and with the ongoing dedication of our team and the continued support of our members, I am confident we will keep growing, innovating, and enhancing the BNA’s role as a leader in neuroscience.

Page 3

BRITISH NEUROSCIENCE ASSOCIATION LIMITED

(A Company Limited by Guarantee)

TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 30 SEPTEMBER 2024

Achievements and performance

a. Aim 1: Inform

Scientific Journal : The Association’s scientific journal, Brain and Neuroscience Advances, remains the platform through which we inform the profession about the latest neuroscience research. In November 2022, we were pleased to welcome Dr. Kate Baker (University of Cambridge) as co-Editor-in-Chief alongside Professor Jeff Dalley. This year, Professor Dalley stepped down after 8 years of exemplary leadership. Dr. Baker has since led the journal admirably, ensuring its continued relevance and value for BNA members. We extend our gratitude to Professor Dalley for his dedication and service.

This year we have maintained the number of articles published in the journal:

These figures show consistent output compared to the previous year, maintaining the journal’s reach and academic contributions. We remain dedicated to advancing the publication and dissemination of high-quality neuroscience research and look forward to the continued success of Brain and Neuroscience Advances. Dr. Baker, along with the BNA Trustees and Executive Team, has been working closely with our publisher, Sage, to increase submissions and publications. Although the numbers reflect stability rather than growth, this consistency underscores our commitment to maintaining a high standard of content while actively working to broaden the journal's future impact.

Informing members : Keeping our members informed is an essential role performed by the BNA, whether that’s informing each other about the BNA community’s ‘internal’ activities or informing them about external factors that are relevant to the field as a whole.

This year marked a significant milestone for the BNA as we published the 100th and final print issue of the BNA Bulletin. This strategic decision reflects our evolving approach to communications, transitioning from a seasonal print newsletter to more dynamic, online content that supports member engagement and offers greater opportunities for members to contribute. By focusing on digital platforms, we aim to make Brain and Neuroscience Advances our primary communication outlet, while also encouraging more member writing across multiple formats.

We are deeply grateful to all our members who have contributed over the years, particularly the ECR Brain Insights team, whom we will continue to work with to create engaging digital content. Special thanks also go to Ian Jones, our BNA Bulletin Editor since 2012.

External communications : The website and the BNA’s social media platforms are essential resources for connecting with both members and non-members.

This year, the BNA Council approved a long-overdue upgrade to the BNA website and integrated membership management system. The new website is set to launch in May 2025 and is designed to boost member engagement with key BNA activities.

By the end of this reporting period, the BNA experienced a significant increase in followers across our social media channels. This growth is largely attributed to the recruitment of a Marketing and Communications Manager (0.6 FTE) in March 2024, who has dedicated considerable time and effort to our communications strategy. A consistent and professional brand identity across all platforms has played a pivotal role in increasing visibility and enhancing engagement with our online audience.

Page 4

(A Company Limited by Guarantee)

BRITISH NEUROSCIENCE ASSOCIATION LIMITED

TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 30 SEPTEMBER 2024

Achievements and performance (continued)

Training : In YE2024, the BNA made significant progress in developing a structured training programme to support the neuroscience community. Building on our commitment to professional development, we have been working behind the scenes to create the BNA Training Academy, set to launch in YE2025.

This initiative will offer high-quality training opportunities tailored to neuroscientists at all career stages, with a particular focus on skills that support employability and career progression. The academy will include a mix of inperson and online training, covering topics such as research integrity, industry collaboration, communication skills, and neuroscience-specific professional development.

Throughout 2024, we have worked closely with members, industry partners, and training experts to design a programme that is relevant, accessible, and impactful. We are excited to bring this vision to life in 2025, ensuring BNA members and the wider neuroscience community have access to the skills and knowledge they need to thrive.

Page 5

BRITISH NEUROSCIENCE ASSOCIATION LIMITED

(A Company Limited by Guarantee)

TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 30 SEPTEMBER 2024

Achievements and performance (continued)

b. Aim 2: Connect

Connecting the neuroscience community through BNA membership : Over the course of YE2024 we saw membership make a significant increase from 2,653 to 2,992 (+339). This is a huge improvement on our small growth of +32 members from YE2022-23. The table below shows membership trends over the past 3 years:

In 2024, we saw significant growth in our student and postgraduate membership categories, with many new members joining the BNA for the first time. To support this momentum, our Executive team now includes a dedicated Membership and Communities Manager, as well as a Marketing and Communications Manager. These roles are focused on implementing targeted recruitment and retention strategies, ensuring sustained membership growth and engagement across all categories.

BNA Local Groups : The BNA has a national network of 44 Local Groups (LGs) each headed by a Local Group Representative (LGR). Many groups also have one or more Local Group Student Representatives (LGSRs).

LGRs provide a point of contact for members of a Local Group to access a number of member benefits within the BNA. In 2023-24, £13,660 was granted to 14 BNA Local Groups to deliver local events for their members.

A selection of LG activities for which funding was awarded during YE2024 are listed below:

In September 2024, the LGRs and LGSRs met in Birmingham for the annual Local Group Forum, and the online monthly meetings of LGRs have also continued. The connection to members via the Local Groups scheme remains a valuable way of engaging with our members to explore opportunities that are of value to the community.

BNA Meetings : Bringing people together via events is essential for the BNA to fulfil its aim to connect. Through our meetings we enable neuroscientists to connect with each other, across disciplines and geographies, and goes towards meeting our object to “disseminate information to all those interested in the neurosciences and related disciplines”.

Page 6

BRITISH NEUROSCIENCE ASSOCIATION LIMITED

(A Company Limited by Guarantee)

TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 30 SEPTEMBER 2024

Achievements and performance (continued)

During this reporting period we held a number of online and in person meetings during the reporting period, including:

The BNA delivered sessions and represented our members at 2 international conferences: RCPsych International Congress (Edinburgh - June 2024), FENS Forum 2024 (Vienna - June 2024).

The BNA was successful is our bid to host the prestigious FENS Forum in Glasgow in 2028. Organised by the Federation of European Neuroscience Societies (FENS), this major international event will bring together thousands of neuroscientists from across the globe to explore the latest breakthroughs in brain research. The BNA is proud to have led this effort, securing the opportunity to showcase the UK's neuroscience community on the global stage and foster international collaboration.

Membership of societies : The BNA is a member of three organisations which make sure the BNA membership is part of a larger voice. Membership of the Royal Society of Biology (RSB) connects us with all the life sciences across the UK. The Federation of European Neuroscience Societies (FENS) enables the BNA and BNA members to be part of European neuroscience, and membership of the International Brain Research Organisation (IBRO) connects the BNA with the global community.

Page 7

(A Company Limited by Guarantee)

BRITISH NEUROSCIENCE ASSOCIATION LIMITED

TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 30 SEPTEMBER 2024

Achievements and performance (continued)

c. Aim 3: Influence

As the largest UK-based organisation representing neuroscience and neuroscientists, the BNA is in position to influence the sector, decision-makers, and neuroscientists themselves. Having influence is central in fulfilling two of the Association’s objects: (c) Advising as far as possible on issues in neurosciences related to health and disease; and (f) Representing the interests of neuroscience researchers and promoting the case for the advancement of neuroscience research in the United Kingdom to government, to agencies providing research funding and to bodies engaged in science administration, regulation and standards. Our main areas of activity in the area of ‘influence’ are listed below.

Grant Partnerships : In YE2024, as part of our ongoing efforts to redefine and strengthen our value proposition to partners, the BNA developed a comprehensive Grant Partnership Offer. This new initiative positions us to partner, co-deliver, and advise on research grant proposals, further amplifying our influence in the sector and creating new opportunities for collaboration. Over the course of the review period, we played a key role in 9 grant applications, ranging from UKRI grants to internal university funding and government initiatives, including the Office for Life Sciences.

Of the 9 applications submitted, 4 were successful, 2 were unsuccessful, and 3 are still pending decision. The total value of grants applied for, with funding directed to the BNA, amounted to £246,811. From these successful applications, £92,776 has been approved, which will be allocated over the next five years, providing an additional annual income of approximately £10,000.

Grant delivery will officially begin in YE2025 and will include a variety of impactful activities such as BNA representation on scientific advisory boards and steering committees, the delivery of workshops, convening the neuroscience community, co-developing policy papers, and disseminating grant outputs through our networks. Additionally, we will promote these grant activities to our members, ensuring that they directly benefit from the outputs and knowledge generated.

All grant-related initiatives align with the BNA’s core mission and purpose, ensuring that we continue to support and represent the neuroscience community while driving forward the advancement of neuroscience research and policy.

Credibility in Neuroscience : We are now five years into our campaign to “support the neuroscience sector to increase the transparency, reproducibility, replicability and reliability of neuroscience research”.

In June 2024, we held training workshop in Bristol to bring together researchers at PhD or postdoc level to learn how they should plan to ensure their projects are as reproducible as possible, and how they can deliver this by making their research data and code open.

Our journal, Brain and Neuroscience Advances is one of only a handful of journals worldwide to cover the full range of open science practices – being Gold Open Access, offering Registered Reports, CRediT taxonomy, Transparency and Openness Promotion (TOP) Guidelines and Badges for Open Practices.

Equity, diversity and inclusion (EDI) in neuroscience : The role the BNA has in this space continues to grow, and the Association is committed to influencing and increasing EDI in our sector.

Our most significant activity is the ongoing management and growth of the BNA Scholars Programme. In YE2024, the programme welcomed a further 7 Scholars to support a total of 28 students and Early Career Researchers from under-represented ethnic groups to flourish in neuroscience. Notably, in July 2024, we funded the attendance of seven Scholars to the FENS Forum in Vienna, where they joined nearly 8,000 neuroscientists; three of them presented their research during conference poster sessions. We are grateful to our Supporters for hosting and enabling these events and career development opportunities.

Page 8

(A Company Limited by Guarantee)

BRITISH NEUROSCIENCE ASSOCIATION LIMITED

TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 30 SEPTEMBER 2024

Achievements and performance (continued)

Beyond the Scholars Programme, the BNA has actively engaged in national EDI advocacy. In November 2023, we issued an open letter to UK Research and Innovation (UKRI) expressing disappointment over the suspension of the Research England EDI Expert Advisory Group. We highlighted concerns that this action could disrupt UKRI's initiatives to promote diversity and inclusion within the research sector and urged for the group's prompt reinstatement. Following an independent investigation, UKRI found no evidence of misconduct and reinstated the EDI Expert Advisory Group in March 2024.

In recognition of our leadership's dedication to EDI, we are proud to announce that in July 2024, our PresidentElect, Professor Narender Ramnani of Royal Holloway, University of London, was awarded the 2024 ALBAFKNE Diversity Prize. This prestigious award, jointly presented by the ALBA Network and the FENS-Kavli Network of Excellence, honors individuals who have made outstanding contributions to promoting diversity and inclusion in brain research. Professor Ramnani's efforts include challenging the diversity of UKRI's Research Council Committees and playing a pivotal role in establishing the BNA Scholars Programme.

A voice in UK Parliaments : The BNA is a member of the Parliamentary and Scientific Committee (P&SC). This committee is an interface between scientists and parliamentarians and provides opportunities for the BNA to inform decision-making that takes place in both the House of Commons and the House of Lords, and enables us to raise awareness of issues that we feel are important for neuroscientists. The BNA was represented at P&SC meetings throughout the year.

In September 2024, the BNA held its first event at the Welsh Parliament. The event, sponsored by Hefin David MS (Caerphilly), emphasized the significance of Welsh neuroscience and the contributions of Welsh Higher Education Institutions among Welsh policymakers. This gathering united academics, clinicians, politicians, research funders, charities, and industry representatives to showcase the breadth of neuroscience research in Wales. Discussions highlighted the collaborative culture and extensive networks among Welsh research institutions, the NHS, charities, and industry, which facilitate the translation of research from bench to bedside. The event underscored Wales' leadership in mental health and neuroscience, showcasing collaboration and innovation at the forefront of research.

Strengthening leadership and representation in neuroscience : In the past year, the British Neuroscience Association (BNA) has significantly enhanced its influence through notable appointments and engagements:

These developments underscore the BNA's growing leadership and representation within the neuroscience community and beyond.

Animals in Research : The BNA continues to be committed to openness on the use of animals in research and is a signatory of the Concordat on Openness on Animal Research in the UK. We are an active member of the RSB’s Animal Science Group (a special interest group representing the broad spectrum of UK bodies actively involved in supporting, funding, or formulating policy on research involving animals), and the UK Bioscience Sector Coalition (which represents the collective views of the bioscience sector with an interest in the use of animals in research).

Page 9

BRITISH NEUROSCIENCE ASSOCIATION LIMITED

(A Company Limited by Guarantee)

TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 30 SEPTEMBER 2024

Achievements and performance (continued)

BNA prizes : This year, the BNA launched the Green Neuroscience prize. The prize is awarded for efforts by neuroscience researchers in making positive steps to reduce the environmental impact of their own research activities. Our inaugural winner is Nick Souter, University of Sussex.

Winners of the BNA’s annual prizes in YE2024 were as follows:

This year, we launched the Neuroscience Nominations Network to champion BNA members for international prizes, awards, and leadership positions. The network comprises individuals with strong connections across the UK neuroscience community, including those with past or present roles in BNA governance and local group networks. The group submits nominations for prestigious international awards such as FENS, SfN, and The Brain Prize. Through this initiative, we aim to elevate the global profile of our members and further celebrate and support our community.

Financial review

a. Going concern

After making appropriate enquiries, the Trustees have a reasonable expectation that the Charity has adequate resources to continue in operational existence for the foreseeable future. For this reason they continue to adopt the going concern basis in preparing the financial statements. Further details regarding the adoption of the going concern basis can be found in the Accounting Policies.

b. Financial review

During the financial year ending 30 September 2024, the BNA’s total income was £434,297 (2023: £322,934). Expenditure, which was wholly on charitable activities to advance education in neuroscience, was £409,476 (2023: £364,725); after taking account of net gains on investments, the net movement in funds was a surplus of £73,618 (2023: deficit of £11,791).

The net reserves carried forward was £659,558 (2023: £585,940). Of this, £103,294 (2023: £118,960) is held in restricted funds, committed largely to (1) delivering activities associated with funding from the Gatsby Charitable Foundation, and (2) supporting the BNA’s equity, diversity and inclusion work.

Funding has and will continue to be used to support the BNA Trustees’ ten-year strategic plan, in particular the activities which meet the aims to ‘Inform, Connect and Influence’.

The BNA is in a stable financial position to sustain itself and to meet its charitable objectives.

Page 10

BRITISH NEUROSCIENCE ASSOCIATION LIMITED

(A Company Limited by Guarantee)

TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 30 SEPTEMBER 2024

c. Reserves policy

The BNA’s reserves policy states that unrestricted funds which have not been designated for a specific use should be maintained at a level equivalent to one year’s expenditure, where one year’s expenditure is calculated on the basis of:

The Trustees consider that reserves at this level will ensure that, in the event of a significant drop in revenue, they will be able to continue the Association’s current activities while consideration is given to ways in which additional funds may be raised and/or costs can be reduced. The level of this reserve will be maintained throughout the course of each accounting year.

d. Principal funding

The main sources of income for the BNA in 2024 were membership subscriptions of £116,624 (2023: £106,391) and grants and donations of £213,790 (2023: £215,144), which includes £160,000 from The Gatsby Charitable Foundation.

e. Investment policy and objectives

The Trustees’ investment powers are governed by Article 5 in the Articles of Association. This permits the Charity to deposit or invest funds in securities or property as may be thought fit in order to further its Objects, or is conducive or incidental to doing so, subject to conditions and consents as laid down in the Association’s governing documents.

The Trustees’ policy for YE2025 will be to continue to optimise income on temporarily invested funds and to maintain a balanced portfolio of long-term investments, and continue to manage the Charity’s investments in conformity with our policy and Trust Deed.

Structure, governance and management

a. Constitution

British Neuroscience Association Limited is a company limited by guarantee, as defined by the Companies Act 2006. The Company is registered as a charity under the registration number 1103852.

The BNA is governed by its Memorandum and Articles of Association, and accompanying set of Rules. No changes have been made to governing articles since 2017.

Page 11

(A Company Limited by Guarantee)

BRITISH NEUROSCIENCE ASSOCIATION LIMITED

TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 30 SEPTEMBER 2024

Structure, governance and management (continued)

b. Organisational structure

The British Neuroscience Association is a membership organisation, with seven membership categories (defined in the Rules), plus a number of Honorary members. With the exception of Associate members, all members have voting rights on the principle of “one member, one vote”, which is exercised at the Annual General Meetings (detailed in Articles 15-27).

The Association has 44 Local Groups (Rule 5), that provide for a national network between members and the Association’s governance team.

The BNA is governed by a Council of Trustees, comprising between seven and twelve members of the Association (Article 29). Non-Trustee positions on the Council include the Meetings Secretary, other co-opted members for specific functions and other invited observers or advisors. The specific procedures for the appointment and retirement of the Trustees are detailed in the Articles (32-35).

To help with discharging the activities of the Association, the BNA has also a National Advisory Committee (formerly “The National Committee”) whose role is to represent different demographics and interests within the Association’s membership (Rule 4).

Supporting all activities and needs of the Council, Committee, and general membership is the BNA Executive. During the year this consisted of two full time and three part-time staff members.

c. Risk management

The Trustees have a duty to identify and review the risks to which the Charity is exposed and to ensure appropriate controls are in place to provide reasonable assurance against fraud and error. Potential risks, once identified, will be monitored and controlled to mitigate any impact that they may have on the Association in the future.

To help with this the BNA has a Risk Register. Conflict of Interest (Rules 8 and 9) and a Register of Interests. BNA has a specific Declaration of Interests form, that is completed by all members of the Council and Committee of the BNA.

Page 12

(A Company Limited by Guarantee)

BRITISH NEUROSCIENCE ASSOCIATION LIMITED

TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 30 SEPTEMBER 2024

Plans for future periods

The strategic pillars of the BNA remain ‘Inform, Connect, Influence’.

At the start of YE2025, key priorities are as follows:

1. CONNECT: Engaging our membership and connecting the community In 2025, we will continue to strengthen engagement with our members at both local and national levels, ensuring they experience tangible value from their BNA membership and feel a strong sense of belonging within our community.

Building on the progress made in YE2024 with the recruitment of a Marketing and Communications Manager and a Membership and Communities Manager, we will implement our new membership management system and website. This long-overdue upgrade will enhance the member experience, making it easier for members to engage with our activities, access resources, and stay connected.

A major highlight of the year will be the delivery of The International Festival of Neuroscience, BNA2025, our flagship international conference, taking place in Liverpool. This event will provide a unique opportunity to bring together neuroscientists from across sectors and around the world, further cementing the BNA’s role as a leading force in neuroscience collaboration and knowledge exchange.

2. INFORM: Professionalising the sector

A key highlight of 2025 will be the launch of the BNA Training Academy, which will provide a comprehensive suite of training courses for neuroscientists at all career stages. These courses will offer opportunities to enhance professional skills, with content aimed at both members and non-members, including clinicians and industry professionals. This initiative will not only deliver value to our members but also provide a new avenue to engage non-member sectors and generate additional revenue for the organisation.

We will also continue to focus on career development, offering targeted opportunities for our early career and student members. By offering these resources, we aim to support the next generation of neuroscientists in their career progression and ensure they are equipped with the skills necessary for success in a rapidly evolving field.

3. INFLUENCE: Policy, Advocacy and Credibility

In 2025, the BNA will continue to strengthen its policy and advocacy efforts across the UK, building on the successes of our engagements in the devolved nations. Following our events in Scotland and Wales, we will host an event in England, further connecting with our members and engaging with the UK Parliament. This will allow us to continue advocating for the importance of neuroscience research and to elevate the voices of our members within national policy discussions.

We will also continue to champion our members by strategically positioning them for international roles, prizes, and recognition. This will increase connectivity across organisations and countries, enhancing the global visibility and influence of BNA members. By working with partners worldwide, we aim to open new doors for collaboration and ensure that UK neuroscientists are well-represented on the international stage.

Additionally, we will further develop our Grant Partnerships programme, which has proven to be an important avenue for both revenue generation and enhancing our credibility within the neuroscience sector. In 2025, we aim to begin delivery of our confirmed grant partnership efforts, ensuring BNA members are directly involved in the delivery of high-impact research, policy development, and cross-sector workshops. By leveraging our growing influence, we will continue to build collaborative relationships.

These activities will allow us to remain at the forefront of neuroscience advocacy and continue positioning the BNA as a key player in global neuroscience discussions and research advancements.

Page 13

(A Company Limited by Guarantee)

BRITISH NEUROSCIENCE ASSOCIATION LIMITED

TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 30 SEPTEMBER 2024

Reference and administrative details

Members of BNA Council

appointed April 2023 elected April 2023 elected May 2022 appointed April 2023 appointed April 2023 elected May 2022

elected May 2022 elected May 2022 appointed April 2017 appointed April 2017 appointed April 2017 elected September 2024 appointed October 2021 appointed September 2023

Members of the National Committee

elected April 2023 appointed May 2022 appointed May 2022 elected September 2024)

Executive

Page 14

BRITISH NEUROSCIENCE ASSOCIATION LIMITED

(A Company Limited by Guarantee)

TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 30 SEPTEMBER 2024

Statement of Trustees' responsibilities

The Trustees (who are also the directors of the Charity for the purposes of company law) are responsible for preparing the Trustees' Report and the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice).

Company law requires the Trustees to prepare financial statements for each financial . Under company law, the Trustees must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the Charity and of its incoming resources and application of resources, including its income and expenditure, for that period. In preparing these financial statements, the Trustees are required to:

The Trustees are responsible for keeping adequate accounting records that are sufficient to show and explain the Charity's transactions and disclose with reasonable accuracy at any time the financial position of the Charity and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the Charity and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

Approved by order of the members of the board of Trustees and signed on their behalf by:

................................................ P= Professor T L Spires-Jones President

Date: 1 April 2025

Page 15

(A Company Limited by Guarantee)

BRITISH NEUROSCIENCE ASSOCIATION LIMITED

INDEPENDENT EXAMINER'S REPORT FOR THE YEAR ENDED 30 SEPTEMBER 2024

Independent Examiner's Report to the Trustees of British Neuroscience Association Limited ('the Charity')

I report to the charity Trustees on my examination of the accounts of the Charity for the year ended 30 September 2024.

Responsibilities and Basis of Report

As the Trustees of the Charity (and its directors for the purposes of company law) you are responsible for the preparation of the accounts in accordance with the requirements of the Companies Act 2006 ('the 2006 Act').

Having satisfied myself that the accounts of the Charity are not required to be audited under Part 16 of the 2006 Act and are eligible for independent examination, I report in respect of my examination of the Charity's accounts carried out under section 145 of the Charities Act 2011 ('the 2011 Act'). In carrying out my examination I have followed the Directions given by the Charity Commission under section 145(5)(b) of the 2011 Act.

Independent Examiner's Statement

Since the Charity's gross income exceeded £250,000 your examiner must be a member of a body listed in section 145 of the 2011 Act. I confirm that I am qualified to undertake the examination because I am a member of Institute of Chartered Accountants in England and Wales, which is one of the listed bodies.

I have completed my examination. I confirm that no matters have come to my attention in connection with the examination giving me cause to believe:

  1. accounting records were not kept in respect of the Charity as required by section 386 of the 2006 Act; or

  2. the accounts do not accord with those records; or

  3. the accounts do not comply with the accounting requirements of section 396 of the 2006 Act other than any requirement that the accounts give a 'true and fair' view which is not a matter considered as part of an independent examination; or

  4. the accounts have not been prepared in accordance with the methods and principles of the Statement of Recommended Practice for accounting and reporting by charities [applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102)].

I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the accounts to be reached.

Page 16

(A Company Limited by Guarantee)

BRITISH NEUROSCIENCE ASSOCIATION LIMITED

INDEPENDENT EXAMINER'S REPORT (CONTINUED) FOR THE YEAR ENDED 30 SEPTEMBER 2024

This report is made solely to the Charity's Trustees, as a body, in accordance with Part 4 of the Charities (Accounts and Reports) Regulations 2008. My work has been undertaken so that I might state to the Charity's Trustees those matters I am required to state to them in an Independent Examiner's Report and for no other purpose. To the fullest extent permitted by law, I do not accept or assume responsibility to anyone other than the Charity and the Charity's Trustees as a body, for my work or for this report.

Signed: Dated: 01-04-25

Martin Bailey FCA

Goodman Jones LLP 1st Floor Arthur Stanley House 40-50 Tottenham Street London W1T 4RN

Page 17

BRITISH NEUROSCIENCE ASSOCIATION LIMITED

(A Company Limited by Guarantee)

STATEMENT OF FINANCIAL ACTIVITIES (INCORPORATING INCOME AND EXPENDITURE ACCOUNT) FOR THE YEAR ENDED 30 SEPTEMBER 2024

Note
Income from:
Donations and legacies
4
Charitable activities
5
Investments
6
Total income
Expenditure on:
Charitable activities
7
Total expenditure
Net income/(expenditure) before net
gains on investments
Net gains on investments
Net movement in funds
Reconciliation of funds:
Total funds brought forward
Net movement in funds
Total funds carried forward		 Unrestricted
funds
2024
£
9,405
110,752
103,883
224,040
183,553
183,553
40,487
48,797
89,284
466,980
89,284
556,264		 Restricted
funds
2024
£
204,385
5,872
-
210,257
225,923
225,923
(15,666)
-
(15,666)
118,960
(15,666)
103,294		 Total
funds
2024
£
213,790
116,624
103,883
434,297
409,476
409,476
24,821
48,797
73,618
585,940
73,618
659,558		 Total
funds
2023
£
215,144
106,391
1,399
322,934
364,725
364,725
(41,791)
30,000
(11,791)
597,731
(11,791)
585,940

The Statement of Financial Activities includes all gains and losses recognised in the year.

The notes on pages 21 to 34 form part of these financial statements.

Page 18

BRITISH NEUROSCIENCE ASSOCIATION LIMITED

(A Company Limited by Guarantee) REGISTERED NUMBER: 04307833

BALANCE SHEET AS AT 30 SEPTEMBER 2024

Note
Fixed assets
Tangible assets
11
Investments
12
Current assets
Debtors
13
Cash at bank and in hand
Creditors: amounts falling due within one
year
14
Net current assets
Total assets less current liabilities
Total net assets
Charity funds
Restricted funds
15
Unrestricted funds
15
Total funds		 25,827
229,528
255,355
(4,769)		 2024
£
955
408,017
408,972
250,586
659,558
659,558
103,294
556,264
659,558		 20,509
215,993
236,502
(11,438)		 2023
£
1,656
359,220
360,876
225,064
585,940
585,940
118,960
466,980
585,940

The Charity was entitled to exemption from audit under section 477 of the Companies Act 2006.

The members have not required the company to obtain an audit for the year in question in accordance with section 476 of Companies Act 2006.

The Trustees acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to entities subject to the small companies regime.

Page 19

BRITISH NEUROSCIENCE ASSOCIATION LIMITED

(A Company Limited by Guarantee)

BALANCE SHEET (CONTINUED) AS AT 30 SEPTEMBER 2024

The financial statements were approved and authorised for issue by the Trustees and signed on their behalf by:

................................................ Professor T L Spires-Jones Professor T L Spires-Jones President Director

Date: 1 April 2025

The notes on pages 21 to 34 form part of these financial statements.

Page 20

BRITISH NEUROSCIENCE ASSOCIATION LIMITED

(A Company Limited by Guarantee)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 SEPTEMBER 2024

1. General information

British Neuroscience Association Limited is a Charitable Company Registered in England and Wales. The registered office address is Dorothy Hodgkin Building, Whitson Street, Bristol BS1 3NY.

The Charity is a company limited by guarantee. The members of the company are the Trustees named on page 1. In the event of the Charity being wound up, the liability in respect of the guarantee is limited to £1 per member of the Charity.

2. Accounting policies

2.1 Basis of preparation of financial statements

The financial statements have been prepared in accordance with the Charities SORP (FRS 102) - Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019), the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) and the Companies Act 2006.

British Neuroscience Association Limited meets the definition of a public benefit entity under FRS 102. Assets and liabilities are initially recognised at historical cost or transaction value unless otherwise stated in the relevant accounting policy.

The financial statements are prepared in sterling, which is the functional currency of the Charity. Monetary amounts in these financial statements are rounded to the nearest £.

2.2 Going concern

After making appropriate enquiries, the Trustees have a reasonable expectation that the Charity has adequate resources to continue in operational existence for the foreseeable future. The Trustees have considered the future plans of the Charity and expected income, and it is deemed that the Charity can meet its commitments and liabilities and can continue for the foreseeable future. Accordingly, they continue to adopt the going concern basis in preparing the financial statements.

2.3 Fund accounting

General funds are unrestricted funds which are available for use at the discretion of the Trustees in furtherance of the general objectives of the Charity and which have not been designated for other purposes.

Restricted funds are funds which are to be used in accordance with specific restrictions imposed by donors or which have been raised by the Charity for particular purposes. The costs of raising and administering such funds are charged against the specific fund. The aim and use of each restricted fund is set out in the notes to the financial statements.

Investment income, gains and losses are allocated to the appropriate fund.

Page 21

BRITISH NEUROSCIENCE ASSOCIATION LIMITED

(A Company Limited by Guarantee)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 SEPTEMBER 2024

2. Accounting policies (continued)

2.4 Income

All income is recognised once the Charity has entitlement to the income, it is probable that the income will be received and the amount of income receivable can be measured reliably.

Other income is recognised in the period in which it is receivable and to the extent the goods have been provided or on completion of the service. Membership fees are recongised in the period to which they relate.

Grant income is recognised when the Charity has entitlement to the funds, any performance conditions attached to the grants have been met, it is probable that the income will be received, and the amount can be measured reliably.

2.5 Interest receivable

Interest on funds held on deposit is included when receivable and the amount can be measured reliably by the Charity; this is normally upon notification of the interest paid or payable by the institution with whom the funds are deposited.

2.6 Expenditure

Expenditure is recognised once there is a legal or constructive obligation to transfer economic benefit to a third party, it is probable that a transfer of economic benefits will be required in settlement and the amount of the obligation can be measured reliably. Expenditure is classified by activity. The costs of each activity are made up of the total of direct costs and shared costs, including support costs involved in undertaking each activity. Direct costs attributable to a single activity are allocated directly to that activity. Shared costs which contribute to more than one activity and support costs which are not attributable to a single activity are apportioned between those activities on a basis consistent with the use of resources. Central staff costs are allocated on the basis of time spent, and depreciation charges allocated on the portion of the asset’s use.

Expenditure on charitable activities is incurred on directly undertaking the activities which further the Charity's objectives, as well as any associated support costs.

Grants payable are charged in the year when the offer is made except in those cases where the offer is conditional, such grants being recognised as expenditure when the conditions attaching are fulfilled. Grants offered subject to conditions which have not been met at the year end are noted as a commitment, but not accrued as expenditure.

All expenditure is inclusive of irrecoverable VAT.

2.7 Tangible fixed assets and depreciation

Tangible fixed assets are initially recognised at cost. After recognition, under the cost model, tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. All costs incurred to bring a tangible fixed asset into its intended working condition should be included in the measurement of cost.

Page 22

(A Company Limited by Guarantee)

BRITISH NEUROSCIENCE ASSOCIATION LIMITED

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 SEPTEMBER 2024

2. Accounting policies (continued)

2.7 Tangible fixed assets and depreciation (continued)

Depreciation is charged so as to allocate the cost of tangible fixed assets less their residual value over their estimated useful lives, on a reducing balance basis.

Depreciation is provided on the following basis:

Computer equipment

2.8 Investments

Fixed asset investments are a form of financial instrument and are initially recognised at their transaction cost and subsequently measured at fair value at the Balance Sheet date, unless the value cannot be measured reliably in which case it is measured at cost less impairment. Investment gains and losses, whether realised or unrealised, are combined and presented as ‘Gains/(Losses) on investments’ in the Statement of Financial Activities.

Investments in subsidiaries are valued at cost less provision for impairment.

2.9 Debtors

Trade and other debtors are recognised at the settlement amount after any trade discount offered. Prepayments are valued at the amount prepaid net of any trade discounts due.

2.10 Cash at bank and in hand

Cash at bank and in hand includes cash and short-term highly liquid investments with a short maturity of three months or less from the date of acquisition or opening of the deposit or similar account.

2.11 Liabilities and provisions

Liabilities are recognised when there is an obligation at the Balance Sheet date as a result of a past event, it is probable that a transfer of economic benefit will be required in settlement, and the amount of the settlement can be estimated reliably.

Liabilities are recognised at the amount that the Charity anticipates it will pay to settle the debt or the amount it has received as advanced payments for the goods or services it must provide.

Provisions are measured at the best estimate of the amounts required to settle the obligation. Where the effect of the time value of money is material, the provision is based on the present value of those amounts, discounted at the pre-tax discount rate that reflects the risks specific to the liability. The unwinding of the discount is recognised in the Statement of Financial Activities as a finance cost.

2.12 Financial instruments

The Charity only has financial assets and financial liabilities of a kind that qualify as basic financial instruments. Basic financial instruments are initially recognised at transaction value and subsequently measured at their settlement value with the exception of bank loans which are subsequently measured at amortised cost using the effective interest method.

Page 23

BRITISH NEUROSCIENCE ASSOCIATION LIMITED

(A Company Limited by Guarantee)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 SEPTEMBER 2024

2. Accounting policies (continued)

2.13 Pensions

The Charity operates a defined contribution pension scheme and the pension charge represents the amounts payable by the Charity to the fund in respect of the year.

3. Critical accounting estimates and areas of judgement

Estimates and judgements are continually evaluated and are based on historical experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances.

Critical accounting estimates and assumptions:

The Charity makes estimates and assumptions concerning the future. The resulting accounting estimates and assumptions will, by definition, seldom equal the related actual results. No estimates and assumptions that have a significant risk of causing a material adjustment to the carrying amounts of assets and liabilities within the next financial year have been identified.

4. Income from donations and legacies

Unrestricted
funds
2024
£
Donations
9,405
Total 2023
16,376		 Restricted
funds
2024
£
204,385
198,768		 Total
funds
2024
£
213,790
215,144		 Total
funds
2023
£
215,144

5. Income from charitable activities

Unrestricted
funds
2024
£
Subscriptions and Bulletin advertising
110,752
Total 2023
106,391		 Restricted
funds
2024
£
5,872
-		 Total
funds
2024
£
116,624
106,391		 Total
funds
2023
£
106,391

Page 24

(A Company Limited by Guarantee)

BRITISH NEUROSCIENCE ASSOCIATION LIMITED

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 SEPTEMBER 2024

6.
Investment income
Unrestricted
funds
2024
£
Dividend income
100,000
Bank interest
3,883
Total 2024
103,883
Total 2023
1,399		 Total
funds
2024
£
100,000
3,883
103,883
1,399		 Total
funds
2023
£
-
1,399
1,399

7. Analysis of expenditure on charitable activities Summary by fund type

Unrestricted
funds
2024
£
Advance education in neuroscience
183,553
Total 2023
199,415		 Restricted
funds
2024
£
225,923
165,310		 Total
2024
£
409,476
364,725		 Total
2023
£
364,725

8. Analysis of expenditure by activities

Advance education in neuroscience
Total 2023		 Activities
undertaken
directly
2024
£
256,701
203,948		 Support
costs
2024
£
152,775
160,777		 Total
funds
2024
£
409,476
364,725		 Total
funds
2023
£
364,725

Page 25

BRITISH NEUROSCIENCE ASSOCIATION LIMITED

(A Company Limited by Guarantee)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 SEPTEMBER 2024

8. Analysis of expenditure by activities (continued)

Analysis of direct costs

Advance
education in
neuroscience
2024
£
Staff costs
127,230
Bulletin production
18,585
Conference expenses
1,172
Bursaries and sponsorship
8,805
Gatsby project costs
89,816
Subscriptions and membership
7,716
Advertising
6,877
Travel
-
Printing, postage and stationery
-
Telephone
-
Journal production
(3,500)
Total 2024
256,701
Total 2023
203,948		 Total
funds
2024
£
127,230
18,585
1,172
8,805
89,816
7,716
6,877
-
-
-
(3,500)
256,701
203,948		 Total
funds
2023
£
115,164
27,860
-
-
33,031
10,103
4,790
7,256
45
675
5,024
203,948

Page 26

(A Company Limited by Guarantee)

BRITISH NEUROSCIENCE ASSOCIATION LIMITED

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 SEPTEMBER 2024

8. Analysis of expenditure by activities (continued)

Analysis of support costs

Advance
education in
neuroscience
2024
£
Staff costs
122,300
Depreciation
701
Advertising
1,875
Travel
6,264
Printing, postage and stationery
70
Telephone
819
Website development
4,162
Professional fees
8,693
Insurance
1,531
Bank charges
1,937
Sundry
2,155
Governance
2,268
Bad debt
-
Total 2024
152,775
Total 2023
160,777		 Total
funds
2024
£
122,300
701
1,875
6,264
70
819
4,162
8,693
1,531
1,937
2,155
2,268
-
152,775
160,777		 Total
funds
2023
£
111,711
701
3,622
7,682
123
816
1,992
7,637
1,161
16,842
4,472
3,888
130
160,777

Governance costs include independent examination fees of £2,500 (2023: £2,500).

Page 27

(A Company Limited by Guarantee)

BRITISH NEUROSCIENCE ASSOCIATION LIMITED

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 SEPTEMBER 2024

9. Staff costs

Wages and salaries
Social security costs
Contribution to defined contribution pension schemes		 2024
£
225,518
18,993
5,019
249,530		 2023
£
201,553
16,025
9,297
226,875

The average number of persons employed by the Charity during the year was as follows:

2024 2023
No. No.
Employees 6 5

The number of employees whose employee benefits (excluding employer pension costs) exceeded £60,000 was:

2024 2023
No. No.
In the band £70,001 - £80,000 1 -

Total remuneration, including employer's national insurance and pension contributions, in respect of key management personnel totalled £82,571 (2023: £57,524).

10. Trustees' remuneration and expenses

During the year, no Trustees received any remuneration or other benefits (2023 - £NIL) .

During the year ended 30 September 2024, Trustee expenses have been incurred of £1,211 (2023 - £NIL to 0 Trustees ) in respect of 7 trustees for travel expenses.

Page 28

BRITISH NEUROSCIENCE ASSOCIATION LIMITED

(A Company Limited by Guarantee)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2024
11.
Tangible fixed assets
Cost or valuation
At 1 October 2023
At 30 September 2024
Depreciation
At 1 October 2023
Charge for the year
At 30 September 2024
Net book value
At 30 September 2024
At 30 September 2023		 Office
equipment
£
5,360
5,360
3,704
701
4,405
955
1,656

Page 29

(A Company Limited by Guarantee)

BRITISH NEUROSCIENCE ASSOCIATION LIMITED

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 SEPTEMBER 2024

12. Fixed asset investments

Cost or valuation
At 1 October 2023
At 30 September 2024
Net book value
At 30 September 2024
At 30 September 2023		 Investments
in
subsidiary
companies
£
100
100
100
100		 Other
investments
£
407,917
407,917
407,917
407,917		 Total
£
408,017
408,017
408,017
408,017

Other investments comprise funds held with investment managers for capital growth and income generation.

Principal subsidiaries

The following was a subsidiary undertaking of the Charity:

Name Company Class of Holding
number shares
BNA Events Limited 07784689 Ordinary 100%
The financial results of thesubsidiaryfor theyearwere:
Name Profit/(Loss) Net assets
for the year £
£
BNA Events Limited (31,566) 26,698

Page 30

BRITISH NEUROSCIENCE ASSOCIATION LIMITED

(A Company Limited by Guarantee)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 SEPTEMBER 2024

13. Debtors

Due within one year
Trade debtors
Amounts owed by group undertakings
Prepayments and accrued income		 2024
£
9,609
13,679
2,539
25,827		 2023
£
(256)
14,254
6,511
20,509

14. Creditors: Amounts falling due within one year

Other creditors
Accruals and deferred income		 2024
£
2,269
2,500
4,769		 2023
£
3,438
8,000
11,438

Page 31

(A Company Limited by Guarantee)

BRITISH NEUROSCIENCE ASSOCIATION LIMITED

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 SEPTEMBER 2024

15. Statement of funds

Statement of funds - current year

Unrestricted funds
General Funds - all funds
Restricted funds
Wolstencroft fund
Journal fund
Gatsby Charitable Foundation
Guarantors of Brain
Equity, diversity and inclusion
(EDI)
Total funds		 Balance at 1
October
2023
£
466,980
6,500
196
78,174
11,995
22,095
118,960
585,940		 Income
£
224,040
-
7,534
160,000
5,000
37,723
210,257
434,297		 Expenditure
£
(183,553)
-
(2,000)
(192,830)
-
(31,093)
(225,923)
(409,476)		 Gains/
(Losses)
£
48,797
-
-
-
-
-
-
48,797		 Balance at
30
September
2024
£
556,264
6,500
5,730
45,344
16,995
28,725
103,294
659,558

Page 32

(A Company Limited by Guarantee)

BRITISH NEUROSCIENCE ASSOCIATION LIMITED

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 SEPTEMBER 2024

15. Statement of funds (continued)

Statement of funds - prior year

Unrestricted funds
General Funds - all funds
Restricted funds
Wolstencroft fund
Journal fund
Gatsby Charitable Foundation
Guarantors of Brain
Equity, diversity and inclusion
(EDI)
Total funds		 Balance at
1 October
2022
£
512,229
6,500
300
51,077
9,792
17,833
85,502
597,731		 Income
£
124,166
-
4,920
160,000
5,000
28,848
198,768
322,934		 Expenditure
£
(199,415)
-
(5,024)
(132,903)
(2,797)
(24,586)
(165,310)
(364,725)		 Gains/
(Losses)
£
30,000
-
-
-
-
-
-
30,000		 Balance at
30
September
2023
£
466,980
6,500
196
78,174
11,995
22,095
118,960
585,940

Restricted funds comprise the following:

Wolstencroft fund - for expenses in regard to a lecture on ‘Outstanding Neuroscience’ at the biennial BNA Festival.

Journal fund - for editing and general running of the journal.

Gatsby Charitable Foundation - to support the implementation of the BNA's new strategic plan.

Guarantors of Brain - funding for Equity, diversity and inclusion (EDI) in neuroscience education.

Equity, diversity and inclusion (EDI) - funding to support Equity, diversity and inclusion (EDI) in neuroscience education.

Page 33

BRITISH NEUROSCIENCE ASSOCIATION LIMITED

(A Company Limited by Guarantee)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 SEPTEMBER 2024

16. Analysis of net assets between funds

Analysis of net assets between funds - current period

Unrestricted
funds
2024
£
Tangible fixed assets
955
Fixed asset investments
408,017
Current assets
152,061
Creditors due within one year
(4,769)
Total
556,264		 Restricted
funds
2024
£
-
-
103,294
-
103,294		 Total
funds
2024
£
955
408,017
255,355
(4,769)
659,558

Analysis of net assets between funds - prior period

Tangible fixed assets
Fixed asset investments
Current assets
Creditors due within one year
Total		 Unrestricted
funds
2023
£
1,656
359,220
117,542
(11,438)
466,980		 Restricted
funds
2023
£
-
-
118,960
-
118,960		 Total
funds
2023
£
1,656
359,220
236,502
(11,438)
585,940

17. Pension commitments

The Charity operates a defined contributions pension scheme. The assets of the scheme are held separately from those of the Charity in an independently administered fund. The pension cost charge represents contributions payable by the Charity to the fund and amounted to £5,019 (2023: £9,297). Contributions of £977 (2023: £968) were owed to the fund at the balance sheet date.

18. Related party transactions

During the year, the Charity received an amount totalling £100,000 (12023: £nil) from BNA Events Limited, its wholly-owned subsidiary, in respect of distribution of profits for the year ended 30 September 2023. At the balance sheet date, the Charity was owed £13,679 (2023: £14,254) by BNA Events Limited.

Other than disclosed above or elsewhere in these financial statements, there were no other transactions with related parties requiring disclosure.

Page 34